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Abstract: Background: Patients with a bicuspid aortic valve (BAV) have an increased risk for aortic
dilation and dissection. In this study, we provide a histological stratification of the developing
aorta in the tricuspid aortic valve (TAV) and the BAV populations as a reference for future studies
on aortopathy and related syndromes. Methods: Non-dilated TAV and BAV ascending aortic wall
samples were collected, including 60 TAV (embryonic–70 years) and 32 BAV specimens (fetal–72
years, categorized in eight age groups. Results: In TAV, intimal development starts in the neonatal
phase. After birth, the thickness of the medial layer increases significantly by increase of elastic
lamellae up to and including the “young child” phase stabilizing afterwards. The BAV shows already
prenatal intimal thickening becoming significantly thinner after birth subsequently stabilizing. In BAV,
increase in elastic lamellae is seen between the young child and the adolescent phases, stabilizing
afterwards. Conclusions: Vascular development in TAV is described in three phases: maturation,
stabilization, and degeneration. For BAV, the development can be described in two phases: maturation
(already prenatally) and degeneration. After birth, the development of the aorta is characterized by
degeneration, leading to weakening of the ascending aortic wall and increasing the risk of aortopathy.
Keywords: bicuspid aortic valve; tricuspid aortic valve; development; aortopathy; histopathology
1. Introduction
The vascular system within the thorax contains major elastic arteries, including the ascending and
the descending aorta, the pulmonary trunk, and the pulmonary arteries. Development of the vascular
system involves a complex sequence of inductive and differentiating signals that lead to vasculogenesis
starting by the formation of an endothelial plexus in the splanchnic mesoderm. The differentiation of
the great arteries starts by stabilization of the endothelial network (arteriogenesis) with the recruitment
of vascular smooth muscle cells (VSMCs) from the surrounding splanchnic mesoderm as well as the
neural crest and through endothelial smooth muscle cell transformation [1]. Throughout the vascular
J. Clin. Med. 2020, 9, 908; doi:10.3390/jcm9040908 www.mdpi.com/journal/jcm
J. Clin. Med. 2020, 9, 908 2 of 19
system, there are many sources for these VSMCs [2–4]. In general, the great arteries acquire an elastic
phenotype during development opposed to a muscular phenotype of the more peripheral arteries.
The elastic arteries have specific characteristics that differ between the ascending and the descending
aorta [5] as well as the pulmonary trunk [6].
The morphogenetic processes underlying the differences in the structure of the elastic arteries [5]
and the muscular arteries are still poorly understood. Most probably, these are the results of origin
of the endothelial and the VSMC populations in combination with the role of hemodynamics [7].
The great arteries in general are more influenced by high shear stress and pressure.
Developmental data on the origin of the endothelial and the VSMCs of the ascending aorta show
a prominent role for neural crest derived cells as well as second heart field derived cells [8,9]. It is
important to realize that these cell types are not only present in the ascending aortic wall but are also
part of the forming semilunar valves of both the aorta and the pulmonary trunk, although in a different
composition [10]. Therefore, an early embryonic defect of the neural crest cells and/or the second
heart field cells could lead to the development of both an abnormal valve and defects in the VSMC
differentiation, as is seen in patients with a bicuspid aortic valve (BAV) [11].
In the adult vascular wall, the VSMCs are highly specialized cells with contraction and regulation
of blood vessel tone-diameter as primary function. Unlike cardiac muscle cells, adult VSMCs are not
terminally differentiated and retain the possibility to undergo a phenotypic switch in response to local
environmental cues [12]. During vascular development, VSMCs play a key role in differentiation of the
vessel wall and exhibit high rates of proliferation and production of extracellular matrix components
(e.g., collagen, elastin, fibrillin, and proteoglycans) while acquiring contractile properties [13]. At this
stage of development, VSMCs form numerous gap junctions with endothelial cells, and this process of
investment of endothelial tubes with VSMCs is crucial for vascular maturation [14]. In adult human
blood vessels, the VSMCs are characterized by a low rate of proliferation/turnover and a very low rate
of synthesis of extracellular matrix components and thus are completely dedicated to carry out their
contractile function. However, in response to vascular injury, the VSMCs can dramatically increase
their rate of proliferation, migration, and synthetic capacity, which plays a crucial role in vascular
repair [13,15]. The ability to switch between a “contractile” and a “synthetic” phenotype is an important
property of the differentiated VSMCs. However, the possibility to undergo a phenotypic switch in
response to environmental cues also plays an important role in the development of major diseases,
such as atherosclerosis [15–17].
In our previous research, we concluded that, in patients with a developmental defect in aortic
valvulogenesis, being a BAV, the ascending aortic wall is characterized by VSMC immaturity due
to a lack of differentiation of the VSMCs. While comparing nondilated and dilated tricuspid aortic
valve (TAV) and BAV specimens, we further found that the adult intimal layer of the latter was
significantly thinner compared to the TAV specimens [18,19]. In the early 1950s, Wilens described
the intima of the aorta at birth consisting merely of a single layer of endothelium superimposed
directly on its own reticular basement membrane or on that of the innermost elastic lamella of the
media [20]. The infantile intima is merely a surface layer of endothelial cells. Postnatally, the aortic
intima acquires a subendothelial fibrous zone of rather uniform width and becomes separated from the
media by a zone of randomly arrayed VSMCs and elastic tissue [20,21]. Based on the abovementioned
historical description of the intimal layer, the BAV intima seems premature. As, to this day, only
adult ascending aortic wall specimens have been studied—and these have mostly been studies about
atherosclerosis—we cannot decide whether the ascending aortic wall features in BAV are due to a
delay in maturation or due to an underlying maturation defect.
Understanding the development of the ascending aorta ranging from fetal stage to adulthood is
mandatory to generate an overall view of the aging aorta as a reference to compare with syndromes
associated with aortopathy such as BAV. This triggered the current study in which we investigated
an upclimbing series of aortic wall specimens in the normally developed TAV from early to late
fetal through neonatal, child, and adolescent stages to the already earlier investigated older adult
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population [18,19]. These specimens were then compared to age matched aortic wall tissues of
BAV patients.
The aim of this study is to generate an overview of the developing aorta in the TAV and the BAV
populations as a reference for future studies on aorta histopathology and aortopathy.
2. Material and Methods
2.1. Patients and Tissue Samples and Ethical Approval
All adult samples included in this study were non-dilated, defined as a diameter of the ascending
aorta of less than 45 mm. Serial sections of postmortem fetal hearts were selected from the Leiden
Collection (Department of Anatomy and Embryology, LUMC, Leiden, the Netherlands) in order to
examine the ascending aortic wall of BAV and TAV. The age of these fetal specimens ranged from 10
weeks + days gestational age (GA) to 15 years. Adolescent BAV and TAV and adult TAV specimens
were obtained post-mortem from the Pathology Department (LUMC). Additionally, young child to
adolescent TAV specimens (age ranging from 2–18 years) were obtained from the Pathology Department
of the Erasmus Medical Center (EMC) in Rotterdam. The purpose of collecting these valuable samples
in the EMC was to use them as a “reference group” to compare to aortopathy samples. Adult BAV and
TAV specimens were obtained during surgery from the aortotomy site when the preferred stentless
aortic root replacement was performed [17] in the LUMC. We only included patients with an isolated
BAV, while patients with a congenital cardiac anomaly besides a BAV were excluded (e.g., coarctation
of the aorta, ventricular septal defect, Tetralogy of Fallot). None of the included patients died of a
cardiac or a vessel-related cause. A total of 60 TAV (age ranging from 10 weeks GA–70 years) and
32 BAV (age ranging from 17.5 weeks + days GA–72 years) patients were included (Table 1).
Table 1. Gives an overview of the samples included in the study.
Age Categories Tricuspid Aortic ValveN = 60
Bicuspid Aortic Valve
N = 32
Premature (<38 weeks gestational age)
N = 6
• 10 WK (n = 1)
• 18 WK (n =1)
• 19 WK (n = 2)
• 21.5 WK, D (n = 1)
• 23 WK (n = 1)
N = 5
• 17.5 WK, D (n = 1)
• 19 WK (n = 1)
• 20 WK (n = 1)
• 36 WK (n = 1)
• 37.6 WK, D (n = 1)
Neonate (0 < 30 days)
N = 5
• 1 D (n = 2)
• 2 D (n = 1)
• 11 D (n = 1)
• 13 D (n = 1)
• 21 D (n = 1)
N = 6
• 1 D (n = 2)
• 2 D (n = 1)
• 11 D (n = 1)
• 13 D (n = 1)
• 21 D (n = 1)
Infant (1 month < 2 years)
N = 6
• 1 M (n = 1)
• 4 M (n = 1)
• 6 M (n = 2)
• 9 M (n = 1)
• 1.5 Y (n = 1)
N = 6
• 1 M (n = 1)
• 3 M (n = 2)
• 4 M (n = 1)
• 5.5 M (n = 1)
• 11 M (n = 1)
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Table 1. Cont.
Age Categories Tricuspid Aortic ValveN = 60
Bicuspid Aortic Valve
N = 32
Young child (2 < 6 years)
N = 9
• 2 Y (n = 5)
• 3 Y (n = 2)
• 4 Y (n = 1)
• 5 Y (n = 1)
N = 2
• 2 Y (n = 1)
• 4 Y (n = 1)
Child (6 < 12 years)
N = 1
• 6 Y (n = 1) N = 0
Adolescent (12 < 18 years)
N = 22
• 12 Y (n = 3)
• 13 Y (n = 1)
• 14 Y (n = 3)
• 15 Y (n = 5)
• 16 Y (n = 3)
• 17 Y (n = 7)
N = 4
• 12 Y (n = 2)
• 13 Y (n = 1)
• 15 Y (n = 1)
Young adult (18 < 21 years)
N = 5
• 18 Y (n = 5) N = 0
Adult (> 21 years)
N = 6
• 47 Y (n = 1)
• 56 Y (n = 1)
• 59 Y (n = 1)
• 61 Y (n = 1)
• 70 Y (n = 1)
• 70 Y (n = 1)
N = 9
• 41 Y (n = 1)
• 42 Y (n = 1)
• 47 Y (n = 1)
• 50 Y (n = 1)
• 56 Y (n = 1)
• 62 Y (n = 1)
• 65 Y (n = 1)
• 70 Y (n = 1)
• 72 Y (n = 1)
Overview of all specimens included in the study. WHO= World Health Organization; BAV = bicuspid aortic valve;
TAV = tricuspid aortic valve; WK,D = weeks, days gestational age, M = month, Y = year.
This study was undertaken in accordance with the local ethics committee and the Dutch regulation
for the proper use of human tissue for medical research purposes.
Embryonal, fetal, neonate, and infant aortic specimens used in our manuscript were obtained
from the Leiden Collection of (malformed) hearts obtained from autopsies (Department of Anatomy
and Embryology, Leiden, The Netherlands), a collection of hearts preserved in ethanol and glycerine
dating from the 1950s in an era where no formal approval was in effect. The material was anonymized,
and no privacy rules were violated. Furthermore, this study was conducted in accordance with the
LUMC institutional guidelines for the use of human tissue and the Declaration of Helsinki.
The World Health Organization suggested the following age categories in 2007 on the basis of
earlier described pediatric categories [22]: premature < 38 weeks gestational age; neonate 0 < 30 days
of age; infant 1 month < 2 years; young child 2 < 6 years; child 6 < 12 years, adolescent 12 < 18 years,
young adults 18 < 21years and adults > 21 years of age. According to their definition, we clustered our
material in 16 categories (Table 1). As the “child” group only contained one patient of 6 years in the
TAV group, we decided to combine the young child and the child groups, which are collectively called
the “young child” group hereafter.
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2.2. Sample Processing, Routine Histology, and Immunohistochemistry
The sectioning and staining protocols were described previously [23]. In summary, specimens
obtained from hearts from our collection in the LUMC were fixed in formalin, decalcified, embedded in
paraffin, and subsequently sectioned (4 µm). The sections were stained with hematoxylin-eosin (HE),
resorcin fuchsin (RF), and Movat pentachrome. The immunohistochemical staining protocol used for
αSMA (1/5000 -A2547, Sigma-Aldrich Chemie, Zwijndrecht, the Netherlands) was described in our
previous study [18]. All specimens were evaluated by two independent, experienced histopathologists
who were blinded to the clinical data.
To describe the aortic wall in a standardized way, we used terms from the grading system
described in the recent aortic consensus paper [24]. Terms used in this scoring system are overall
medial degeneration (EMD), elastic fiber fragmentation and loss (EFF/L), elastic fiber thinning (EFT),
elastic fiber disorganization (EFD), mucoid extra cellular matrix accumulation (MEMA), and smooth
muscle cell nuclei loss (SMCNL). In our previous study [25], we suggested a modification of the
aortic consensus statement grading system: the so called pathology score with addition of the intimal
thickness and a number of immunohistochemical based features: (1) medial VSMC differentiation;
(2) expression of αSMA; (3) intimal architecture including subendothelial layer structure and the
absolute intimal thickness in µm; (4) intimal atherosclerosis indexed as 0 (none), 2 (mild), 4 (moderate),
or 6 (severe). Most of the features scored were, however, related to cardiovascular pathology and
therefore were not applicable to the pre- and the postnatal normal aortic tissues. In the current study,
we performed a part of the pathology scoring system to describe the appearance of immaturity. We
focused on the development of the elastic lamellae and the intimal layer with aspects of EFT, EFF, and
MEMA. In RF stained sections, the maximum intimal and medial thicknesses were quantified in µm.
We further calculated the ratio between the vessel’s intima thickness and the total vessel wall thickness
and counted the number of elastic lamellae in the media and the interlamellar distance in the inner,
the middle, and the outer media.
2.3. Histologic Parameters and Morphometry
Sections were studied with a Leica BM500 microscope equipped with plan achromatic objectives
(Leica Microsystems, Wetzlar, Germany). EMD, EFF/L, EFT, EFD, MEMA, and SMCNL were graded
semi-quantitatively in HE, αSMA, RF, and MOVAT stained sections in the aortic media. All features
were indexed as 0 (none), 2 (mild), 4 (moderate), or 6 (severe) on three predetermined locations (left,
middle, and right) of every section, which we refer to as “microscopic fields” maintained in evaluation
of all stainings on sister sections. Expression of the VSMC marker αSMA in the intimal layer was
graded as being present or not. The elastic lamellae were counted manually in the RF stained sections
by two independent observers.
2.4. Statistical Analysis
All numerical data are presented as mean ±SD of three microscopic fields on each stained slide.
For comparison between the groups, statistical differences were evaluated with the Mann–Whitney
U-test. One, two, and threeway ANCOVA tests were performed to correct for age and gender.
Significance was assumed when p < 0.05 using SPSS 20.0 software program (SPSS Inc. Chicago, MI,
USA). Graphpad software was used to create graphics of statistical analysis.
3. Results
The ascending aortic wall in adults is historically divided in three layers: the internal layer
(tunica intima); the middle layer (tunica media); and the outer layer (tunica adventitia). The tunica
intima is mostly described consisting of a single layer of endothelial cells lining the aortic lumen on
top of a subendothelial layer of loosely organized elastic fibers and VSMCs. The tunica media is
known to contain four major elements: VSMCs, elastic fibers arranged in lamellar units, collagen, and
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the interposed glycosaminoglycans. The outer part of the tunica media also contains vasa vasorum
originating in the tunica adventitia. The tunica adventitia predominantly consists of loose fibrous tissue
containing collagen, nerve fibers, fibroblasts, adipocytes, and vasa vasorum lined by endothelium
and VSMCs.
As this study focuses on the developmental stages of the wall of the ascending aorta, we decided
not to adhere solely to the already described vascular wall architecture, but in addition, we described
the different elements in upclimbing stages for the normal developing vascular wall in TAV compared
to age-matched BAV patients.
3.1. Development of the Innermost Layer of the Ascending Aorta
The youngest TAV was a 10 weeks GA with an endothelial intimal layer and only showing a
thick internal elastic lamina (lamina elastica interna, LEI) as a border with the middle layer of the
ascending aorta (Figure 1A,B). This morphology was also seen in the neonatal phase until the age of
1 month (Figure 1). The single layer of the LEI was negative for alpha smooth muscle actin (αSMA)
staining (Figure 1C,D). At the age of 4 months, the intima developed a subendothelial layer and
started to increase in thickness. The LEI still bordered the tunica media (Figure 2A,B), but locally
split (Figure 2C), a process that we describe as fanning out of the LEI. Between the endothelial layer
at the luminal surface and the LEI, the subendothelial layer increased gradually in thickness with
age in absolute values, with two outliers at the ages of 4 and 6 months (Figure 3A). With increasing
thickness, the intimal layer contained fine elastic lamellae, which appeared “thinner” and fragmented
as compared to the lamellae in the tunica media (Figure 2D).
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Figure 1. Transverse histological sections of the aortic wall in the non-dilated TAV of 21.5 weeks 
gestational age (A–F) with details (B and D). 1B: arrow pointing towards the lamina elastica interna, 
being negative in the αSMA staining (C,D). In the HE and the RF stained sections (E,F), no pathology 
is seen in the vessel wall. RF: resorcin fuchsin; αSMA: alpha smooth muscle actin; HE: hematoxylin 
eosin; TA: tricuspid valve without dilation; magnification (A,C,E,F 10x; B,D 40x). 
Figure 1. Transverse histological sections of t rtic all in the non-dilated TAV of 21.5 weeks
gestation l age (A–F) with details (B,D). (B): arrow p inting owards the lamina elastica interna, being
negative in the αSMA staining (C,D). In the HE and the RF stained sections (E,F), no pathology is seen
in the vessel wall. RF: resorcin fuchsin; αSMA: alpha smooth muscle actin; HE: hematoxylin eosin; TA:
tricuspid valve without dilation; magnification ((A,C,E,F) 10×; (B,D) 40×).
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Figure 2. Transverse histological section of the aortic wall in the non-dilated TAV of 4 months old (A 
–D) with details, stained with RF. 2A: Overview of ascending aortic wall with a detail (2B) of the 
intimal layer indicated with the dashed red line. 2C: The lamina elastica interna fanning out to form 
an intimal layer in between. 2D: The dashed line indicates the intimal layer, with the arrow pointing 
at the fine elastic lamellae in the intima, which appear “thinner” and fragmented as compared to the 
lamellae in the tunica media. RF: resorcin fuchsin; TA: tricuspid valve without dilation; magnification 
(A 10x; B 40x; C,D 50x). 
Figure 2. Transverse histological section of the aortic wall in the non-dilated TAV of 4 months old
(A–D) with details, stained with RF. (A): Overview of ascending aortic wall with a detail (B) of the
intimal layer indicated with the dashed red line. (C): The lamina elastica interna fanning out to form
an intimal layer in between. (D): The dashed line indicates the intimal layer, with the arrow pointing
at the fine elastic lamellae in the intima, which appear “thinner” and fragmented as compared to the
lamellae in the tunica media. RF: resorcin fuchsin; TA: tricuspid valve without dilation; magnification
((A) 10×; (B) 40×; (C,D) 50×).
However, as the tunica media thickness varied with age (varying from 320 µm to 2000 µm between
fetal and adult specimen), as discussed in the next segment, we decided to calculate the ratio of the
intima thickness to total vessel thickness rather than comparing absolute diameters (Figure 3B). A
trend of increasing intima–total vessel ratio was seen from prematurity until young adulthood, albeit
not statistically significant (Figure 3B). The adult group significantly had the highest intima–total
vessel ratio as compared to all other groups; however, it was not related to atherosclerosis (p = 0.00)
(Figure 3B). At two years of age, the intimal layer was still devoid of αSMA (Figure 4).
The youngest BAV individual was 17.5 weeks + days GA. In contrast to the TAV, this premature
BAV already showed some thickening of the subendothelial layer (Figure 5A), increasing further
during the premature phase (Figure 5B). This thickened space between the endothelium and the LEI
was nearly devoid of αSMA, comparable to the TAVs at this age (Figure 5C). After birth, the intimal
layer became significantly thinner in the BAV group (p = 0.044) (Figure 5D). In the TAV population,
the premature infant remained with a single LEI until the age of 4 months, whereas, in the BAV
population, the premature infant showed a thicker layer between the endothelium and the LEI as
compared to the premature TAVs. This difference between BAV and TAV was not significant (Figure 6A).
After the infant age, the intima in the TAV group increased more in thickness as compared to the BAV
group. The difference between absolute thickness in the WHO defined groups was, however, only
significant between the adult BAV and TAV groups (p < 0.01) (Figure 6A). The MOVAT pentachrome
staining did not show any signs of atherosclerosis in the young age groups.
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Figure 3. Graph 3A showing the intimal thickness (µm). The intimal thickness increases gradually 
with age, with two outliers at 4 and 6 months (indicated with *). Graph 3B shows the ratio between 
the intima and the total vessel thickness. The adult group significantly had the highest intima–total 
vessel ratio as compared to all other groups (p = 0.00). 
Figure 3. Graph (A) showing the intimal thickness (µm). The intimal thickness increases gradually
with age, with two outliers at 4 and 6 months (indicated with *). Graph 3 (B) shows the ratio between
the intima and the total vessel thickness. The adult group significantly had the highest intima–total
vessel ratio as compared to all other groups (p = 0.00).
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Figure 4. Transverse histological section of the aortic wall in the non-dilated TAV of 2 years old. No 
expression of αSMA is seen in the tunica intima (i). TA: tricuspid aortic valve without dilation; αSMA: 
alpha smooth muscle actin; magnification 10x. 
Figure 4. Transverse histological section of the aortic wall in the non-dilated TAV of 2 years old. No
expression of αSMA is seen in the tun ca intima (i). TA: tricuspid aortic valve without dilation; αSMA:
alpha mooth muscle actin; magnification 10×.
For the BAV group, we also calculated the intima–total vessel ratio (Figure 6B), which revealed a
significant decrease after birth (p = 0.01), after which the ratio stabilized. In the adult, the intima–vessel
ratio further decreased and was significantly lower as compared to the premature and the neonate
ratio (p < 0.01).
In childhood, the BAV showed αSMA expression in the intimal layer (Figure 7).
3.2. Development of the Middle Layer of the Ascending Aorta
The middle layer or media was defined as the area between the LEI and the outermost layer,
the adventitia. The media consisted mainly of elastic lamellae, VSMCs, extracellular matrix, and vasa
vasorum being confined to its outer part.
In the premature TAV, the medial layer consisted of neatly organized elastic lamellae without
elastic fiber thinning, fragmentation, or degeneration and with minimal MEMA. Figure 8A shows the
number of lamellae in the various groups in TAV with a significant increase between the premature
and the neonate groups (p = 0.012) between the neonate and the infant groups (p < 0.01) and between
the infant and the young child groups (p < 0.01). The highest number of lamellae was found in the
young child group, after which the number remained stable during childhood. The adolescent group
showed a slight decrease in the number of lamellae as compared to the young child group (p = 0.049),
and the adult group also showed a decrease in number of lamellae as compared to the young child
group (p = 0.018). It was apparent that the intimal layer lacking α-actin remained relatively thin until
the complete number of lamellae was formed. After the number of lamellae was stabilized, we found
that the intimal thickness increased; this was, however, not statistically significant (Figure 8B).
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Figure 5. Transverse histological section of the aortic wall in the non-dilated BAV of 17.5 weeks 
gestational age (A) and 20 weeks gestational age (B, C). Intimal thickening in BAV is already apparent 
in the premature phase (5A and 5B arrow pointing towards tunica intima). The tunica intima is devoid 
of αSMA expression (5C). After birth, the intimal layer becomes significantly thinner in the BAV 
group (p = 0.044) and further decreases in adulthood (p = 0.006) (Graph 5D). RF: resorcin fuchsin; 
αSMA: alpha smooth muscle actin; BA: tricuspid valve without dilation; magnification (A,C 60x; B 
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Figure 5. Transverse histological section of the aortic wall in the non-dilated BAV of 17.5 weeks
gestational age (A) and 20 weeks gestational age (B,C). Intimal thickening in BAV is already apparent
in the premature phase (A and B arrow pointing towards tunica intima). The tunica intima is devoid of
αSMA expression (C). After birth, the intimal layer becomes significantly thinner in the BAV group (p
= 0.044) and further decreases in adulthood (p = 0.006) (Graph D). RF: resorcin fuchsin; αSMA: alpha
smooth muscle actin; BA: tricuspid valve without dilation; magnification ((A,C) 60×; (B) 40×).
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Figure 6. Graph 6A compares the intimal thickness between the TAV and the BAV. The difference 
between absolute thickness in the WHO defined groups is significant between the adult BAV and 
TAV groups (p < 0.01). The intima–total vessel ratio in BAV is seen in Graph 6B, which reveals a 
significant decrease after birth (p = 0.01), after which, the ratio stabilizes. In the adult, the intima–
Figure 6. Graph 6 (A) compares the intimal thickness between the TAV and the BAV. The difference
between absolute thickness in the WHO defined groups is significant between the adult BAV and
TAV groups (p < 0.01). The intima–total vessel ratio in BAV is seen in Graph 6 (B), which reveals a
significant decrease after birth (p = 0.01), after which, the ratio stabilizes. In the adult, the intima–vessel
ratio further decreases and is significantly lower as compared to the premature and the neonate ratio
(p < 0.01).
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Figure 8. Graph 8A shows the number of lamellae in TAV. A significant increase is seen from 
prematurity up to and including the young child phase, after which the number of lamellae decreases 
significantly as compared to the young child phase. Graph 8B shows the intimal thickness and the 
number of lamellae in the TAV group. It is apparent that the intimal layer remains relatively thin until 
the complete lamellae are formed. After the number of lamellae is stabilized, the intimal thickness 
increases. Graph 8C shows the number of elastic lamellae in the BAV. The first significant increase in 
number of lamellae is seen between the young child and the adolescent phases (p < 0.01). The number 
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< 0.01). 
Figure 8. Graph (A) shows the number of lamellae in TAV. A significant increase is seen from prematurity
up to and including the young child phase, after which the number of lamellae decreases significantly
as compared to the young child phase. Graph (B) shows the intimal thickness and the number of
lamellae in the TAV group. It is apparent that the intimal layer remains relatively thin until the complete
lamellae are formed. After the number of lamellae is stabilized, the intimal thickness increases. Graph
(C) shows the number of elastic lamellae in the BAV. The first significant increase in number of lamellae
is seen between the young child and the adolescent phases (p < 0.01). The number of lamellae in the
adolescent and the adult groups is significantly larger than the rest of the groups (p < 0.01).
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The number of lamellae in the BAV group in contrast to the TAV group did not increase significantly
in the early years of life. The first increase was seen between the young child and the child phases after
4 years of age in our population. Subsequently, the number of lamellae remained stable, which did not
decrease in adulthood, as in the TAV population (Figure 8C).
The media could be subdivided in three parts—inner, middle, and outer media—on the basis
of the appearance of the elastic lamellae. The interlamellar distance was greatest in the inner media,
followed by the middle media, while the outer media showed marked compaction of the elastic
lamellae. In the TAV group, the interlamellar distance varied between the groups. Throughout the
premature phase until the young childhood, the interlamellar distance decreased within the inner,
the middle, and the outer media, while the difference between the three layers remained apparent.
From the young child phase, the interlamellar distance increased again but now proportionately in the
inner, the middle, and the outer media (Figure 9A). For the BAV group, the distance remained stable
throughout the years (Figure 9B).
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3.3. Development of the Outer Most Layer of the Ascending Aorta
The adventitia varied in thickness in all age categories, which was dependent on the area where
the section was taken in all age categories. In all groups, this layer was mainly populated by loose
fibrous tissue, large nerve fibers, vasa vasorum, and adipocytes. Over the years, a decrease in size and
number of the nerve fibers and an increase in number of adipocytes were seen for both BAV and TAV.
4. Discussion
In recent years, literature about ascending aortic wall pathology has increased exponentially.
Despite enormous efforts and great progress in research on mechanisms underlying aortopathy, we still
do not know exactly what causes aortic dilation and rupture in a certain patient population. A very
specific group of patients with an increased risk of aortopathy consists of patients with a BAV, with a
population incidence of 1–2%. This congenital anomaly forms the most common heart defect leading to
aortic dilation in 50–70% of affected individuals [26]. Most studies describing histology in aortopathy
patients have, until now, compared the aorta with human adult ascending aortic wall specimens of a
TAV. The pathogenetic mechanism leading to aortopathy can, however, only be understood when the
normal vascular developmental processes are known.
In this paper, we aimed to address the fundamental morphological differences between TAV and
BAV patients. We described, for the first time in more detail, an upclimbing age and differentiation
range of human ascending aortic wall specimens from fetal age until adulthood and compared the
vascular features with an age-matched BAV population. Describing vascular pathology is complex,
and most studies lack a standardization in the methods and the description of the vessel wall, which
hampers understanding of the complex pathogenesis of BAV aortopathy. As the specimens investigated
did not exhibit overt pathology at that young age, the standardized pathology score to describe the
vessel wall could not reveal any differences between the studied groups. We did, however, identify an
important difference in vascular wall development between the TAV and the BAV, which could explain
the increased risk for aortopathy in the latter patient group.
It was previously shown that, in adult BAV, the intima is significantly thinner compared to adult
TAV, whereas the media is significantly thicker in BAV [18]. In this study, we confirmed the significant
difference in intimal thickness between BAV and TAV adults, although the development of the intimal
layer between these two groups was also distinct. In TAV, the intimal development, including formation
of a clear subendothelial layer, starts neonatally (4 months). The LEI “fans out”, leading to formation
of a layer still bordering the media and a more endothelially oriented layer that continues fanning out.
The subendothelial layer increases in thickness with age and also contains the LEI, which continues to
fan out; this layer can now be more easily distinguished. Intimal thickness increases absolutely until
the young child phase, after which the intimal layer stabilizes for a few years and again increases in
thickness during adulthood (Figure 10). This increase in intimal thickness in TAV should be seen as a
normal physiological process, which is most probably important for strengthening of the vessel and can
be seen as a remarkable ability to adapt to injury and/or regeneration. The intimal proliferation could
aid in coping with high and pulsatile blood pressure. When this intimal proliferation process takes on
pathological forms, it is referred to as arteriosclerosis [27], and when fatty deposits are included, it
is referred to as atherosclerosis [28] with often a deleterious effect on the media. Although the two
terms arteriosclerosis and atherosclerosis are often used interchangeably, these are different processes.
It was in 1955 that a study group was formed in the World Health Organization in order to delimit
atherosclerotic lesions from other alterations (Paterson 1958). They concluded that atherosclerotic
lesions are of focal character different from diffuse intimal thickening. According to Jores [21], diffuse
intimal thickening develops gradually in the first three decades of life. As the MOVAT pentachrome
staining we used did not elucidate that atherosclerosis was present in the young age groups, this
supports our hypothesis that intimal proliferation is a physiological process in TAV. How much the
mechanism of normal intima formation resembles the development of arteriosclerosis can be debated.
In the sense of Jores, it is a compensatory phenomenon in which there is proliferation of the intima and
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the media and in which there is usually involvement of the arterioles seen in pathological conditions,
including pulmonary hypertension [21].
J. Clin. Med. 2020, 9, x FOR PEER REVIEW 18 of 21 
 
Although the WHO age classification used in this paper comprises eight groups, on the basis of 
our study, the vascular development can grossly be summarized in three phases for TAV: maturation, 
stabilization, and degeneration. The maturation phase is characterized by the formation of the elastic 
lamellae and initial intimal thickening, both seen until the (young) childhood phase. Subsequently, 
the increase in intimal thickness and the formation of elastic lamellae stabilize, as is also the case for 
the intima–total vessel ratio. Stabilization lasts until adulthood, after which degeneration sets in with 
a significant increase in intimal thickening, probably coping with changing physiological conditions. 
As for BAV, vascular development can be described in two phases taking place in other stadia than 
in the TAV population: vessel wall maturity and degeneration. Vessel wall maturation takes place 
prenatally. After birth, the development of the aorta is characterized by aspects of degeneration; the 
intimal layer does not further increase in thickness, which attenuates the possibility to respond to 
vascular injury. The VSMCs do not differentiate [18], and hypoxia induces increased degeneration of 
extracellular matrix, leading to the weakening of the ascending aortic wall and increasing the risk of 
aortopathy. 
 
Figure 10. Transverse histological section of the aortic wall in the non-dilated tricuspid aortic valve 
(TA) (10A,B) and the non-dilated bicuspid aortic valve (BA) (10C,D) stained for resorcin fuchsin (RF). 
In TAV, the intimal layer comprises one internal elastic lamina before birth (indicated with a red 
arrow in 10A). The intimal layer increases in thickness during adulthood (border between inner media 
and intima indicated with a red arrow in 10B). In BAV, intimal thickening is already apparent in the 
premature phase (indicated with a red arrow in 10C). The intima is significantly thinner in the adult 
BAV (10D arrow pointing towards tunica intima). TA: non-dilated tricuspid aortic valve, BA: non-
dilated bicuspid aortic valve; BA: Bicuspid valve without dilation; RF: resorcin fuchsin; magnification 
(A–D 5x and inserts 20x). 
Study limitations: A study limitation can be considered the descriptive nature of our 
observations and the relative lack of robustness. However, the access to the upclimbing age series of 
unique aortic wall material of young human individuals is indispensable for further advance in the 
field of the study of aortic wall maturation in health and disease. We designed our study by 
comparing the expression of a panel of markers in the non-dilated TAV and BAV specimens with 
Figure 10. Transverse histological section of the aortic wall in the non-dilated tricuspid aortic valve (TA)
(A,B) and the non-dilated bicuspid aortic valve (BA) (C,D) stained for resorcin fuchsin (RF). In TAV,
the intimal layer comprises one internal elastic lamina before birth (indicated with a red arrow in (A).
The intimal layer increases in thickness during adulthood (border between inner media and intima
indicated with a red arrow in (B). In BAV, intimal thickening is already apparent in the premature
phase (indicated with a red arrow in (C). The intima is significantly thinner in the adult BAV ((D) arrow
pointing towards tunica intima). TA: non-dilated tricuspid aortic valve, BA: non-dilated bicuspid
aortic valve; BA: Bicuspid valve without dilation; RF: resorcin fuchsin; magnification ((A–D) 5× and
inserts 20×).
It is in this respect of interest that we found a different timing of intimal development and a
much thinner intima in BAV, where we know that dilation and even dissection are more common
than in TAV [26]. We showed that, in the BAV population, intimal thickening starts much earlier,
namely prenatally. After birth, strikingly, the intima decreases in thickness to remain a significantly
thinner intimal layer throughout life. A similar thin intima was described in our series of Marfan
specimens [23,29]. This could imply that normal protective intimal proliferation is lacking in BAV
and MFS, which could increase the risk of aortopathy in these patients. As the current study is
descriptive in nature, we need to continue our investigations to further unravel the mechanisms and
the genetic pathways involved in formation of the intima. Transforming growth factor beta (TGF-β),
for instance, which is known for its fibrotic effects, enhances intimal hyperplasia through the production
of extracellular matrix proteins, including the various collagens [30,31]. In a previous study, we already
described in BAV that the intima shows a significantly lower expression of TGF-β and its downstream
mediator phosphorylated SMAD2 in the intima as compared to TAV [19]. The absence of TGF-β in the
BAV intima could therefore explain the lack of intimal hyperplasia [19].
The process of an early intimal development before birth was also described for the development
of the ductus arteriosus (DA). In that specific vessel wall, the function of the physiological intimal
thickening is important for ductal closure after birth [32]. Splitting of the internal elastic lamina to
form the intimal layer, as is seen in our study population, was also described for the development of
the ductus arteriosus [32].
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Postnatally, the medial layer increases in thickness by forming additional elastic lamellae.
The number of lamellae is similar between BAV and TAV adults; however, the timing of the development
of the lamellae in BAV lags behind that of TAV. Slomp et al. studied DA and aortic tissues and found that,
when intimal thickening develops, SMCs in the inner intima migrate, proliferate, and dedifferentiate
into the media upon stimuli present during a lasting period of fetal and neonatal stages [33]. A
similar finding was found in TAV, as the elastic lamellae in the media only start to form after the
intimal proliferation commences. We also found that, initially, the intimal layer is devoid of αSMA
expression, suggestive of migratory VSMCs that build the aortic media, whereas, in adults with a
fully grown media, the intima layer exhibits αSMA expression. In BAV, however, the intima rather
decreases in thickness after birth, as also found in the areas of cytolytic necrosis (CN) in DA. In DA
with CN, dedifferentiation and apoptosis of VSMC occur very rapidly (i.e., within a few days), which
is not accompanied by proliferation and migration of VSMCs. BAV aortas are characterized by
dedifferentiated VSCMs without the ability to undergo a phenotypic switch [18]. Moreover, BAV aortas
also exhibit significantly more apoptosis as compared to the TAV [34,35].
Furthermore, the BAV media is significantly thicker compared to the TAV media [18] despite
a similar number of lamellae. In the current study, we found that this is attributable to an evident
increase in the interlamellar distance. The increase in interlamellar space is caused by, e.g., mucoid
extracellular matrix (ECM), which seems to play an important role in the pathogenesis of aortic
dilation [36]. The integrity of the aortic extracellular matrix may be compromised by an enhanced
activity of matrix metalloproteinases (MMPs), which are crucial in the degradation of ECM proteins.
Overactivity of MMPs is possible by several means, including overproduction by VSMCs of the
aorta and the inflammatory cells in response to inflammation, oxidative stresses, matrix degradation
products, or increased TGFβ-1 activity [19,37,38]. Overexpression of MMPs is a common feature in
aortic aneurysms [39–43]. Particularly, MMP-2 and MMP-9 have been implicated in thoracic aortic
disease [19,39–43]. We also found an increased MMP-9 activity exclusively in BAV patients susceptible
for aortic complications [19]. Recently, it was suggested that a chronic hypoxic environment in the
media of aneurysmal ascending aortic specimens could be responsible for the medial degeneration
seen in aortopathy [44]. Billaud et al. showed in BAV aortic wall thickening that VSMC hyperplasia
and lumen dilation of the vasa vasorum are all changes that could limit nutrient delivery to the tunica
media, leading to overt pathology in the vessel wall [44]. They further observed a down-regulated
expression of angiogenic and hypoxia-related gene targets in the adventitia associated with evidence of
chronic hypoxia in the media in BAV. Interestingly, we found in our previous study that the expression
of hypoxia inducible factor 1 alpha (Hif1α) was also increased in the media of only a subset of patients
vulnerable for future aortic complications [19].
The observed difference in intima and media development in the current study demonstrates
why, throughout life, the intima–total vessel ratio decreases in TAV but increases in BAV.
Although the WHO age classification used in this paper comprises eight groups, on the basis of
our study, the vascular development can grossly be summarized in three phases for TAV: maturation,
stabilization, and degeneration. The maturation phase is characterized by the formation of the elastic
lamellae and initial intimal thickening, both seen until the (young) childhood phase. Subsequently,
the increase in intimal thickness and the formation of elastic lamellae stabilize, as is also the case for
the intima–total vessel ratio. Stabilization lasts until adulthood, after which degeneration sets in with a
significant increase in intimal thickening, probably coping with changing physiological conditions.
As for BAV, vascular development can be described in two phases taking place in other stadia than
in the TAV population: vessel wall maturity and degeneration. Vessel wall maturation takes place
prenatally. After birth, the development of the aorta is characterized by aspects of degeneration;
the intimal layer does not further increase in thickness, which attenuates the possibility to respond to
vascular injury. The VSMCs do not differentiate [18], and hypoxia induces increased degeneration
of extracellular matrix, leading to the weakening of the ascending aortic wall and increasing the risk
of aortopathy.
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Study limitations: A study limitation can be considered the descriptive nature of our observations
and the relative lack of robustness. However, the access to the upclimbing age series of unique aortic
wall material of young human individuals is indispensable for further advance in the field of the study
of aortic wall maturation in health and disease. We designed our study by comparing the expression of
a panel of markers in the non-dilated TAV and BAV specimens with increasing age. A limitation of our
study is that we did not have frozen tissue samples of all the aortic wall specimens we received fixed in
formalin from the various groups. Therefore, we could not perform a Western blot to correlate this to
our findings of immunohistochemistry. According to the WHO, we subdivided the study population
in eight categories. We realize that the number of patients in certain groups is low. However, we still
decided to maintain the subgroups in this study to have a complete picture of upclimbing ages but had
to combine the young child and the child groups in TAV to make statistical analysis possible. To secure
greater confidence in the obtained results as well as determine the underlying mechanisms, an animal
model that investigates the maturation of the ascending aorta using knock down or inhibition of the
differentiation of vascular smooth muscle cells is needed.
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